Hollow Mesoporous Silica Nanoparticles for Dual Chemo-starvation Therapy of Hepatocellular Carcinoma

Pharm Res. 2023 Sep;40(9):2215-2228. doi: 10.1007/s11095-023-03599-6. Epub 2023 Sep 12.

Abstract

Purpose: This study aims at chemotherapy and starvation therapy of HCC via starvation and apoptosis.

Methods: Hollow mesoporous organosilica nanoparticles (HMONs) with the thioether-hybrid structure were developed using an organic/inorganic co-templating assembly approach. Hydrofluoric acid was used to remove the internal MSN core for yielding large radial mesopores for loading drug cargos. The morphology and structure of NPs were determined using TEM and SEM. HMONs were stepwise surface modified with glucose oxidase (GOx), oxygen (O2) and Doxorubicin (DOX), and cancer cell membrane (CCM) for yielding CCM-coated HMONs (targeted stealth biorobots; TSBRs) for starvation, apoptotic, and enhanced cell uptake properties, respectively. The surface area and pore size distribution were determined via BET and BJH assays. The catalytic ability of GOx-modified NPs was measured using in vitro glucose conversion approach authenticated by H2O2 and pH determination assays. MTT assay was used to determine the cytotoxicities of NPs. Cell uptake and apoptotic assay were used for the NPs internalization and apoptosis mechanisms. The subcutaneous HepG2 tumor model was established in mice. The long-term in vivo toxicity was determined using blood assays.

Results: The prepared NPs were spherical, hollow and mesoporous with excellent surface area and pore size distribution. The GOx-modified NPs exhibited excellent catalytic activity. The TSBRs showed better cytotoxicity and reduce the tumor size and weight. The NPs showed long-term safety in vivo.

Conclusion: TSBRs destroyed cancer cells by starvation and chemotherapy in both in-vitro and in-vivo settings which demonstrates its anti-cancer potential.

Keywords: HCC; cancer cell membrane; doxorubicin; glucose oxidase; hollow mesoporous silica.

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular* / drug therapy
  • Doxorubicin / chemistry
  • Drug Delivery Systems
  • Hydrogen Peroxide
  • Liver Neoplasms* / drug therapy
  • Mice
  • Nanoparticles* / chemistry
  • Porosity
  • Silicon Dioxide / chemistry

Substances

  • Silicon Dioxide
  • Hydrogen Peroxide
  • Doxorubicin